Boron neutron capture therapy is being used in Japan to target and treat head and neck tumours. Many other countries are now building facilities. In 2020, Japan became the first country to approve ...

Japan is at the forefront of boron neutron capture therapy (BNCT). It’s the only country to have authorized its clinical use, approving it for the treatment of head and neck cancers in 2020.

If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.

The research appears in the Journal of Controlled Release. Japan became the first country to approve boron neutron capture therapy (BNCT), a type of targeted radiotherapy for cancer, in 2020.

the increased importance of high neutron energies, the increased use of boron neutron capture therapy, promising new developments in detector design, new measured workplace spectra and improved ...